In 2021, the global anxiety disorders and depression treatment market was estimated to be worth US$11.2 billion. By the end of 2032, the market is expected to have reached a worth of around US$ 16.1 billion, based on a projected CAGR of 3.4% over the next 10 years. It is projected that collaborative efforts by …